Corporate Report

Overview

The report presents Seikagaku's glycoscience-focused pharmaceuticals and LAL businesses, including the JOYCLU launch and the Dalton acquisition. It reports fiscal 2020 net sales of ¥27,662 million and 913 consolidated employees. It also describes environmental management through Group-level coordination of energy use and CO2 emissions, alongside horseshoe-crab conservation activities by its U.S. subsidiary.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2020
Period: 1 April 2020 – 31 March 2021
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services